Progressive resistance training + caloric restriction
Progressive resistance training + caloric restriction has been studied in 1 paper since 2022: 1 trial in people. The newest paper, Oct 1, 2022: “Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial”.
1 paper studies it2 findingsUpdated
See all 1 papers on progressive resistance training + caloric restriction
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Following phase I, both groups had similar statistically significant improvements in FLI (mean change (95% CI): PRT+WL, -12 (-20 to -4); WL, -9 (-15 to -4))”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Department of Health, Australian Government and 1 more
- Human trial1
Studies in people
1 study gave progressive resistance training + caloric restriction to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
| Randomized trial12 months | 36 peoplemean±SD age 67.3±5.1 yearsOlder overweight and obese adults with T2D | BMJ open diabetes research & care, Oct 1, 2022 |
What did studies of progressive resistance training + caloric restriction find?
1Studies of progressive resistance training + caloric restriction measured one outcome, fatty liver index.
Fatty liver index
downin humans1
1 study
Fatty liver index
downin humans1
Progressive resistance training + caloric restriction decreases fatty liver index in humans.
“At completion of 6 months, both groups experienced a statistically significant reduction in FLI, with no significant between-group differences for the change after 3 months (interaction, p=0.50) or 6 months (interaction, p=0.56).”
Human trial12 monthsn = 19
BMJ open diabetes research & care
Progressive resistance training + caloric restriction decreases fatty liver index in humans (overweight and obese adults with type 2 diabetes) (-12 (95% CI -20 to -4)).
“Following phase I, both groups had similar statistically significant improvements in FLI (mean change (95% CI): PRT+WL, -12 (-20 to -4); WL, -9 (-15 to -4))”
Human trialoverweight and obese adults with type 2 diabetes6 monthsn = 19
BMJ open diabetes research & care